Evaluation of Manufacturing Lot of StaphVAX

Clinical trial NCT00211900 · COMPLETED

Trial details

NCT number: NCT00211900
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Staphylococcal Infections Chronic Kidney Failure

Start date: 2005-03-01
Primary completion: 2005-08-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.